Gene · 2217
Papers4,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Physiologically based pharmacokinetic model of IgG to predict mother-to-fetus transfer of ustekinumab in pregnant patients with inflammatory bowel disease. | J Pharm Sci | 2025 | 40639462 | PubTator, text mining | PubMed |
| Artificial Internalizing Receptors for Targeted Degradation of Extracellular Proteins. | Adv Sci (Weinh) | 2025 | 40637291 | PubTator, text mining | PubMed |
| Unmasking Anti-CASPR2 Syndrome in a Patient Treated for Myasthenia Gravis in the Era of New Treatments. | Eur J Neurol | 2025 | 40631640 | PubTator, text mining | PubMed |
| Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies. | MAbs | 2025 | 40624840 | PubTator, text mining | PubMed |
| The neonatal Fc receptor (FcRn): Guardian or Trojan Horse in viral infection? | PLoS Pathog | 2025 | 40623027 | PubTator, text mining | PubMed |
| [Novel second-line treatments for immune thrombocytopenia]. | Rinsho Ketsueki | 2025 | 40619232 | PubTator, text mining | PubMed |
| New horizons in systemic sclerosis treatment: advances and emerging therapies in 2025. | RMD Open | 2025 | 40592721 | PubTator, text mining | PubMed |
| FcRn-Driven Nanoengineered Mucosal Vaccine with Multi-Epitope Fusion Induces Robust Dual Immunity and Long-Term Protection Against Brucella. | Vaccines (Basel) | 2025 | 40573898 | PubTator, text mining | PubMed |
| Towards interpretable drug interaction prediction via dual-stage attention and Bayesian calibration with active learning. | PeerJ Comput Sci | 2025 | 40567801 | PubTator, text mining | PubMed |
| Thyroid Eye Disease: Management, Advances, and Future Opportunities. | Endocr Pract | 2025 | 40553958 | PubTator, text mining | PubMed |
| Special Issue: Abstracts of the 11th Congress of the European Academy of Neurology, Helsinki, Finland. | Eur J Neurol | 2025 | 40542607 | PubTator, text mining | PubMed |
| Special Issue: Abstracts of the 11th Congress of the European Academy of Neurology, Helsinki, Finland. | Eur J Neurol | 2025 | 40542568 | PubTator, text mining | PubMed |
| Identification of a direct interaction between the Fab domains of IgG antibodies and human FcRn upon IgG-FcRn complex formation. | Commun Biol | 2025 | 40506471 | PubTator, text mining | PubMed |
| FcRn inhibitors in immune thrombocytopenia: A comprehensive review of therapeutic advances and clinical outcomes. | Cytokine | 2025 | 40505332 | PubTator, text mining | PubMed |
| A review of conjugation technologies for antibody drug conjugates. | Antib Ther | 2025 | 40491604 | PubTator, text mining | PubMed |
| Multi-omics analysis provides new insights into the molecular mechanisms underlying colostral immunoglobulin G absorption in the gut of neonatal goat kids. | Anim Nutr | 2025 | 40487106 | PubTator, text mining | PubMed |
| FcRn-targeted Pluronic F127-Poly (L-lactic Acid) polymersomes for oral insulin delivery. | Eur J Pharm Biopharm | 2025 | 40480445 | PubTator, text mining | PubMed |
| A shark VNAR with cross-species reactivity for serum albumin: Implications for long-term therapeutic applications. | Int J Biol Macromol | 2025 | 40436158 | PubTator, text mining | PubMed |
| Accelerating Biologics PBPK Modelling with Automated Model Building: A Tutorial. | Pharmaceutics | 2025 | 40430895 | PubTator, text mining | PubMed |
| Physiologically Based Pharmacokinetic Modeling of Biologic Case Studies in Monkeys and Humans Reveals the Necessity of an Additional Clearance Term. | Pharmaceutics | 2025 | 40430853 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2217/papers?page=19